Skip to content
2000
Volume 22, Issue 4
  • ISSN: 1386-2073
  • E-ISSN: 1875-5402

Abstract

Objective: A significant proportion of patients with early non-small cell lung cancer (NSCLC) can be cured by surgery. The distant metastasis of tumors is the most common cause of treatment failure. Precisely predicting the likelihood that a patient develops distant metastatic risk will help identify patients who can further intervene, such as conventional adjuvant chemotherapy or experimental drugs. Methods: Current molecular biology techniques enable the whole genome screening of differentially expressed genes, and rapid development of a large number of bioinformatics methods to improve prognosis. Results: The genes associated with metastasis do not necessarily play a role in the pathogenesis of the disease, but rather reflect the activation of specific signal transduction pathways associated with enhanced migration and invasiveness. Conclusion: In this study, we discovered several genes related to lung cancer resistance and established a risk model to predict high-risk patients.

Loading

Article metrics loading...

/content/journals/cchts/10.2174/1386207322666190129111749
2019-05-01
2025-07-05
Loading full text...

Full text loading...

/content/journals/cchts/10.2174/1386207322666190129111749
Loading
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test